U-PLOID BIOTECHNOLOGIES LTD
Company Documents
Date | Description |
---|---|
04/08/254 August 2025 New | Director's details changed for Dr Chloe Amelia Charalambous on 2025-08-01 |
01/08/251 August 2025 New | Confirmation statement made on 2025-08-01 with no updates |
29/05/2529 May 2025 | Resolutions |
20/03/2520 March 2025 | Total exemption full accounts made up to 2025-01-31 |
31/01/2531 January 2025 | Annual accounts for year ending 31 Jan 2025 |
18/12/2418 December 2024 | Registered office address changed from 94 London Road Headington Oxford OX3 9FN England to Building 696, Innovation Building, Bioescalator Old Road Campus, Roosevelt Drive Headington Oxford OX3 7FZ on 2024-12-18 |
08/10/248 October 2024 | Appointment of Doctor Jeremy James Anthony Buzzard as a director on 2024-09-25 |
24/09/2424 September 2024 | Change of details for Dr Chloe Amelia Charalambous as a person with significant control on 2024-09-22 |
24/09/2424 September 2024 | Director's details changed for Dr Chloe Amelia Charalambous on 2024-09-22 |
24/09/2424 September 2024 | Director's details changed for Dr Alexandre Webster on 2024-09-22 |
24/09/2424 September 2024 | Change of details for Dr Alexandre Webster as a person with significant control on 2024-09-22 |
01/08/241 August 2024 | Confirmation statement made on 2024-08-01 with updates |
01/08/241 August 2024 | Director's details changed for Chloe Amelia Charalambous on 2024-07-18 |
01/08/241 August 2024 | Notification of Chloe Amelia Charalambous as a person with significant control on 2024-07-23 |
23/07/2423 July 2024 | Resolutions |
23/07/2423 July 2024 | Sub-division of shares on 2024-07-18 |
19/07/2419 July 2024 | Appointment of Chloe Amelia Charalambous as a director on 2024-07-18 |
18/07/2418 July 2024 | Appointment of Dr Jordan Abdi as a director on 2024-07-18 |
18/07/2418 July 2024 | Statement of capital following an allotment of shares on 2024-07-18 |
22/01/2422 January 2024 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company